NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS
NOTE
1 – DESCRIPTION OF OPERATIONS
Sharing
Services Global Corporation (“Sharing Services”, “we,” or the “Company”), formerly Sharing
Services, Inc., markets and distributes its health and wellness products primarily in the United States and Canada. The Company
is an emerging growth company and was incorporated in the State of Nevada in April 2015. It markets and distributes its products
and services primarily through an independent sales force, which it refers to as “Elepreneurs,” using a marketing
strategy which is a form of direct selling. The Company’s main operating subsidiaries are Elepreneurs Holdings, LLC and
Elevacity Holdings, LLC.
The
Company does not operate retail stores. It markets
its products and services through its independent sales force and using its proprietary websites, including: www.elevacity.com.
The Company’s fiscal year ends on April 30.
Corporate
Name Change
In
January 2019, Sharing Services, Inc. changed its corporate name to Sharing Services Global Corporation to better reflect the Company’s
strategic intent to grow its business globally. In connection with the name change, the Company adopted the trading symbol SHRG
effective April 4, 2019. Prior to this the Company’s common stock traded under the symbol SHRV.
Going
Concern Reporting
The accompanying consolidated financial
statements have been prepared on a going concern basis, which assumes the Company will be able to realize its assets and settle
its liabilities in the ordinary course of its business for the foreseeable future. The Company is an emerging growth company and,
prior to its fiscal quarter ended January 31, 2018, the Company had virtually no sales. However, the Company’s net sales
and/or gross margin generally have increased each quarter since the December 2017 launch of its Elevate health and wellness product
line. For the full fiscal year ended April 30, 2020 and 2019, cash provided by operations was $11.3 million and $6.0 million,
on sales of $131.4 million and $85.9 million, respectively. As of April 30, 2020, cash and cash equivalents were $11.7 million.
The
Company believes it will be able to fund its working capital needs for the next 12 months with existing cash and cash equivalents,
cash to be provided by operations, secured and unsecured debt, including through the issuance of convertible notes and short-term
borrowings under financing arrangements, and capital transactions from time to time. Accordingly, the Company believes it will
be able to continue to operate as a going concern, as defined by U.S. generally accepted accounting principles (“GAAP”),
in the foreseeable future.
NOTE
2 – SIGNIFICANT ACCOUNTING POLICIES
Basis
of Presentation
The
accompanying consolidated financial statements are prepared in accordance with GAAP and include the accounts of the Company and
its consolidated subsidiaries. All significant intercompany accounts and transactions have been eliminated in consolidation.
Reclassifications
Certain
reclassifications have been made to the prior year data to conform with the current period’s presentation.
Comprehensive
Income
For
the fiscal periods covered by this Annual Report, the only component of the Company’s comprehensive income (loss) is the
Company’s net earnings. Accordingly, the Company does not present a consolidated statement of comprehensive income.
Use
of Estimates and Assumptions
The
preparation of financial statements in accordance with GAAP requires the use of judgment and requires management to make estimates
and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses, and disclosures about contingent
assets and liabilities, if any. Matters that require the use of estimates and assumptions include: the recoverability of accounts
receivable, the valuation of inventory, the useful lives of fixed assets, the assessment of long-lived assets for impairment,
the nature and timing of satisfaction of multiple performance obligations resulting from contracts with customers, allocation
of the transaction price to multiple performance obligations in a sales transaction, the measurement and recognition of right-of-use
assets and related lease liabilities, the valuation of derivative liabilities, the valuation of share-based compensation awards,
the measurement and recognition of uncertain tax positions, and the valuation of loss contingencies, if any. Actual results may
differ from these estimates in amounts that may be material to our consolidated financial statements. We believe that the estimates
and assumptions used in the preparation of our consolidated financial statements are reasonable.
Cash
and cash equivalents
Cash
and cash equivalents include cash on hand, demand deposits in banking institutions, and cash equivalents, if any. At April 30,
2020 and 2019, cash and cash equivalents also include $11.1 million and $3.5 million, respectively, of deposits with our merchant
processors, consisting of proceeds from recent sales transactions, which are unrestricted and are not insured by any federal agency.
Cash
equivalents, if any, represent highly liquid short-term investments with an original maturity of 90 days or less and are stated
at cost, which approximates fair value.
Accounts
Receivable and Allowance for Doubtful Accounts
Accounts
receivable consists primarily of amounts due from our merchant processors of $4.2 million and $4.5 million, as of April 30, 2020
and 2019, respectively, including $4.0 million and $4.1 million, respectively, receivable from one merchant processor. We assess
the adequacy of our allowance for doubtful accounts, if any, on the basis of our historical collection data and current information.
Account balances are written off against the allowance after all means of collection have been exhausted and the potential for
recovery is considered remote.
Inventory
and Cost of Goods Sold
Inventory
consists of product held for sale in the normal course of our business. Inventory is stated at the lower of cost, determined using
the first-in, first-out (“FIFO”) method, or net realizable value. Inventory cost reflects direct product costs and
certain shipping and handling costs, such as in-bound freight. When estimating the net realizable value of inventory, we consider
several factors including estimates of future demand for the product, historical turn-over rates, the age and sales history of
the inventory, and historic and anticipated changes in our product offerings.
Physical
inventory counts are performed at all facilities at least annually. Upon completion of physical inventory counts, our consolidated
financial statements are adjusted to reflect actual quantities on hand. Between physical counts, we estimate inventory shrinkage
based on our historical experience. We have policies and processes in place that are intended to minimize inventory shrinkage.
Cost
of goods sold includes actual product costs, vendor rebates and allowances, if any, inventory shrinkage and certain shipping and
handling costs, such as in-bound freight, associated with product sold. All other shipping and handling costs, including the cost
to ship product to customers, are included in selling and marketing expenses in our consolidated statements of operations when
incurred.
Property
and Equipment
Property
and equipment are recorded at cost and reported net of accumulated depreciation. Depreciation expense is recognized over an asset’s
estimated useful life using the straight-line method. Leasehold improvements are amortized over the lesser of the estimated useful
lives of the assets or the term of the related lease, including lease renewals considered reasonably assured. The estimated useful
lives of other property and equipment are as follows:
|
●
|
Furniture
and fixtures – 3 years
|
|
|
|
|
●
|
Office
equipment – 5 years
|
|
|
|
|
●
|
Computer
Equipment – 3 years
|
|
|
|
|
●
|
Computer
software – 3 years
|
|
|
|
|
●
|
Leasehold
improvements – 3 years
|
The
estimated useful lives are periodically reviewed and, when appropriate, changes are made prospectively. The recoverability of
long-lived assets is assessed for impairment whenever events or changes in circumstances indicate that the carrying amount of
an asset may not be fully recoverable, by comparing the net carrying amount of each asset to the total estimated undiscounted
future cash flows expected to be generated by the asset. If the carrying amount of an asset exceeds its undiscounted future cash
flows, an impairment charge is recognized for the amount by which the carrying amount of the asset exceeds the estimated fair
value of the asset.
Revenue
Recognition
The
Company derives revenue only from the sale of its products and services and recognizes revenue net of amounts due to taxing authorities
(such as local and state sales tax). Our customers place sales orders online and through our “back-office” operations,
which creates a contract and establishes the transaction price. The Company recognizes revenue when (or as) it transfers control
of the promised goods and services to the customer. With respect to products sold, our performance obligation is satisfied upon
receipt of the products by the customer. With respect to subscription-based revenue, including Elepreneurs membership fees, our
performance obligation is satisfied over time (up to one year). The timing of our revenue recognition may differ from the time
when we invoice and/or collect payment. The Company has elected to treat shipping and handling costs as an activity to fulfill
its performance obligations, rather than a separate performance obligation.
Deferred
sales revenue associated with product invoiced but not received by customers at the balance sheet date was $2.7 million and $2.5
million as of April 30, 2020 and 2019, respectively. In addition, as of April 30, 2020 and 2019, deferred sales revenue associated
with our performance obligations for services offered on a subscription basis was $433,386 and $515,087, and deferred sales revenue
associated with our performance obligations for customers’ right of return was $263,117 and $194,042, respectively. Deferred
sales revenue is expected to be recognized over one year.
During
the fiscal year ended April 30, 2020, no individual customer, or related group of customers, represents 10% or more of our consolidated
net sales, and approximately 47% of our consolidated net sales were to recurring customers (which we refer to as “SmartShip”
sales), approximately 26% were to new customers and approximately 27% were to our independent distributors. During the fiscal
year ended April 30, 2020 and 2019, approximately 95% and 96%, respectively, of our consolidated net sales are to our customers
and/or independent distributors located in the United States.
During
the fiscal year ended April 30, 2020 and 2019, approximately 98% and 97%, respectively, of our consolidated net sales are from
our health and wellness products (including approximately 25% from the sales of coffee and coffee-related products and approximately
52% from the sale of all other health and wellness products).
During
the fiscal year ended April 30, 2020 and 2019, product purchases from one supplier accounted for approximately 98% and 96%, respectively,
of our total product purchases.
The
Company adopted Accounting Standards Codification (“ASC”) Topic 606, Revenue from Contracts with Customers
(“ASC 606”), effective May 1, 2018, using the cumulative effect transition method. The following table summarizes
the impact of the adoption of ASC 606 on our condensed consolidated balance sheet as of April 30, 2019 and consolidated statement
of operations for the fiscal year ended April 30, 2019:
Impact
of Adoption on the Company’s Condensed Consolidated Balance Sheet
Caption
|
|
As Reported
|
|
|
Excluding the
Impact of ASC 606
|
|
|
ASC 606 Impact
|
|
Inventory
|
|
$
|
2,882,869
|
|
|
$
|
2,282,468
|
|
|
$
|
600,401
|
|
Other current assets
|
|
$
|
373,310
|
|
|
$
|
308,053
|
|
|
$
|
65,257
|
|
Deferred sales revenues
|
|
$
|
3,209,288
|
|
|
$
|
1,611,126
|
|
|
$
|
1,598,162
|
|
Impact
of Adoption on the Company’s Condensed Consolidated Statement of Operations
Caption
|
|
As Reported
|
|
|
Excluding the
Effect of ASC 606
|
|
|
ASC 606 Impact
|
|
Sales
|
|
$
|
85,923,221
|
|
|
$
|
87,521,383
|
|
|
$
|
1,598,162
|
|
Cost of goods sold
|
|
|
28,796,936
|
|
|
|
29,462,594
|
|
|
|
665,658
|
|
Gross Profit
|
|
$
|
57,126,285
|
|
|
$
|
58,058,789
|
|
|
$
|
932,504
|
|
The
“ASC 606 Impact” indicated in the table above reflects the additional deferral of revenue (and related cost of goods
sold) in connection with performance obligations yet to be satisfied at the balance sheet date. In addition, the “ASC 606
Impact” reflects recognition of a right to recover asset associated with our customers’ right of return.
Sales
Commissions
The
Company recognizes sales commission expense when incurred. In the fiscal year ended April 30, 2020 and 2019, sales commission
expense was $59.0 million and $41.5 million, respectively, and is included in selling and marketing expenses in our consolidated
statements of operations.
In
the fiscal year ended April 30, 2019, the Company offered to members of its independent sales force who had met certain sales
targets, fully vested warrants to purchase up to 11,000,000 shares its common stock with an estimated fair value of $1,805,287
(the “2019 Sales-related Warrants”). The warrants are exercisable for a period of two years from the issuance date,
subject to certain default provisions, at the exercise price of $0.25 per share. The rights conferred by the warrants are not
subject to service conditions and all other conditions necessary to earn the award have been satisfied, The Company deems the
fair value of warrants to be an element of sales compensation expense. In the fiscal year ended April 30, 2019, the Company issued
warrants to purchase up to 1,582,600 shares of its common stock, with a fair value of $267,620, pursuant to the program and recorded
an estimated liability in the amount of $1,365,705 in connection with warrants offered but not issued. In the fiscal year ended
April 30, 2020, the Company issued warrants to purchase up to 628,800 shares of its common stock, with a fair value of $95,445,
pursuant to the program. The Company periodically assesses the amount of its estimated liability, including as it relates to the
probability that the additional warrants will be issued pursuant to the program.
In
the fiscal year ended April 30, 2019, sales commission expense includes $1,633,325 associated with the program, including the
estimated liability discussed above. At April 30, 2020 and 2019, accrued sales commission payable was $7,983,536 and $7,402,659,
respectively, and included $1,290,477 and $1,365,705, respectively, in estimated sales compensation payable with stock warrants
in connection with the 2019 Sales-related Warrants.
Share-Based
Payments
Prior
to its fiscal quarter ended April 30, 2019, the Company accounted for share-based consideration issued in exchange of services
by consultants in accordance with the provisions of ASC Topic No. 505, Equity: Equity-based Payments to Non-Employees,
(“ASC 505”). Under ASC 505, the measurement of share-based payment transactions with non-employees is based
on whichever is more reliably determinable: (a) the fair value of the goods or services received, or (b) the fair value of equity
instruments issued. The fair value of the share-based payment transaction is determined at the earlier of the performance commitment
date or the performance completion date.
In
June 2018, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”)
No. 2018-07, Compensation – Stock Compensation (Topic 718) – Improvements to Nonemployee Share-based Payment Accounting
which extended the provisions of ASC Topic 718, Compensation – Stock Compensation (“ASC 718”) to
share-based awards issued to non-employees by public companies. Under ASC 718, among other things, share-based awards to non-employees
must generally be measured at the grant-date fair value of the equity instrument that an entity is obligated to issue, provided
that the services have been rendered and all other conditions necessary to earn the award have been satisfied. As permitted, the
Company adopted the provisions of ASU 2018-07, prospectively, effective February 1, 2019.
In
the fiscal year ended April 30, 2019, sales commission expense includes $1,633,325 in connection the 2019 Sales-related Warrants
discussed above. Please see Note 16 – “Stockholders’ Equity (Deficit)” below for more information about
the Company’s share-based awards.
Lease
Accounting
In
February 2016, the FASB issued ASU No. 2016-02, Leases (“ASU 2016-02), which requires lessees to report on their
balance sheets a right-of-use asset and a lease liability in connection with most lease agreements classified as operating leases
under the prior guidance (ASC Topic 840). Under the new guidance, codified as ASC Topic 842, the lease liability must be measured
initially based on the present value of future lease payments, subject to certain conditions. The right-of-use asset must be measured
initially based on the amount of the liability, plus certain initial direct costs. The new guidance further requires that leases
be classified at inception as either (a) operating leases or (b) finance leases. For operating leases, periodic expense generally
is flat (straight-line) throughout the life of the lease. For finance leases, periodic expense declines over the life of the lease.
The new standard, as amended, provides an option for entities to use the cumulative-effect transition method. As permitted, the
Company adopted ASC Topic 842 effective May 1, 2019 using the optional cumulative-effect transition method, and adoption resulted
in an initial lease liability of approximately $1.4 million and a right to use asset in the same amount. The adoption of ASC Topic
842 did not otherwise have a material impact on the Company’s consolidated financial statements.
The
Company leases space for its corporate headquarters, and additional office and warehouse space, under lease agreements classified
as operating leases under the prior guidance. Please see Note 13 – “Leases” below for more information about
the Company’s leases.
Income
Taxes
The
Company uses the asset and liability method in accounting for income taxes. Accordingly, we recognize deferred income taxes for
the estimated future tax consequences attributable to temporary differences between the financial statement carrying amounts of
existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted
tax rates expected to apply to taxable income in the years in which temporary differences are anticipated to be recovered or settled.
The effect on deferred taxes of a change in income tax rates is recognized in the results of operations in the period that includes
the enactment date. A valuation allowance is recorded to reduce the carrying amounts of deferred tax assets to the amount expected
to be realized unless it is more-likely-than-not that such assets will be realized.
The
Company uses the two-step approach to measure and recognize uncertain tax positions. First, we evaluate the tax position by determining
if the weight of available evidence indicates it is more-likely-than-not that the position will be sustained on audit, including
resolution through related appeals or litigation processes, if any. Secondly, we measure the tax position as the largest amount
which is more-likely-than-not of being realized. The Company considers many factors when evaluating and estimating the Company’s
tax positions, which may require periodic adjustments when new facts and circumstances become known. Please see Note 14 –
“Income Taxes” below for more information about the Company’s accounting for income taxes.
Recently
Issued Accounting Standard - Recently Adopted
In
August 2018, the FASB issued ASU 2018-13, Fair Value Measurement (Topic 820) which modifies the disclosure requirements
on fair value measurements under ASC Topic No. 820, Fair Value Measurement, as amended (“ASC 820”). For public
companies, ASU 2018-13 removes (a) the prior requirement to disclose the amount and reason for transfers between Level 1 and Level
2 of the fair value hierarchy (please see Note 3 – “Fair Value Measurements of Financial Instruments” below),
(b) the policy for timing of transfers between levels, and (c) the valuation processes used for level 3 fair value measurements.
For public companies, ASU 2018-13 also adds, among other things, a requirement to disclose the range and weighted average of significant
unobservable inputs used in Level 3 fair value measurements. The Company adopted ASU 2018-13 effective February 1, 2020 and such
adoption did not have a material effect on its consolidated financial statements.
Recently
Issued Accounting Standards - Pending Adoption
In
November 2019, the FASB issued ASU No. 2019-08, Compensation – Stock Compensation (Topic 718) and Revenue from Contracts
with Customers (Topic 606): Codification Improvements – Share-based Consideration Payable to a Customer (“ASU
2019-08”). ASU 2019-08 requires that an entity apply the guidance in ASC 718 to measure and classify share-based payment
awards granted to a customer. Under ASC 718, among other things, share-based awards to non-employees must generally be measured
at the grant-date fair value of the equity instrument. For entities that have adopted the provisions of ASU 2018-07, Compensation
– Stock Compensation (Topic 718) – Improvements to Nonemployee Share-based Payment Accounting, this amendment
is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. As discussed
above, the Company has adopted the provisions of ASU 2018-07. The Company has not adopted ASU 2019-08 but, based on its preliminary
assessment, does not believe the impact of adoption will be material on its consolidated financial statements.
In
December 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740) – Simplifying the Accounting for Income Taxes
(“ASU 2019-12”). ASU 2019-12, among other things, (a) eliminates the exception to the incremental approach for
intra-period tax allocation when there is a loss from continuing operations and income (or a gain) from other items, (b) eliminates
the exception to the general methodology for calculating income taxes in an interim period when the year-to-date loss exceeds
the anticipated loss for the year, (c) requires than an entity recognize a franchise tax (or a similar tax) that is partially
based on income as an income-based tax and account for any incremental amount incurred as a non-income-based tax, and (d) requires
than an entity reflect the effect of an enacted change in tax laws or rates in the annual effective tax rate computation for the
interim period that includes the enactment date. For public companies, these amendments are effective for fiscal years, and interim
periods within those fiscal years, beginning after December 15, 2020. Early adoption is permitted but must involve the adoption
of all amendments contained in ASU 2019-12 concurrently. The Company has not adopted ASU 2019-12 and is evaluating the potential
impact of adoption on its consolidated financial statements.
NOTE
3 – FAIR VALUE MEASURENTS OF FINANCIAL INSTRUMENTS
Our
financial instruments consist of cash equivalents, if any, accounts receivable, notes receivable, investments in unconsolidated
entities, accounts payable, notes payable and derivative liabilities. The carrying amounts of cash equivalents, if any, accounts
receivable, notes receivable, and accounts payable approximate their respective fair values due to the short-term nature of these
financial instruments.
We
measure on a recurring basis and disclose the fair value of our financial instruments under the provisions of ASC 820, as amended.
We define “fair value” as the price that would be received to sell an asset or paid to transfer a liability (i.e.,
the exit price) in an orderly transaction between market participants at the measurement date. ASC 820 establishes a three-level
hierarchy for measuring fair value and requires entities to maximize the use of observable inputs and minimize the use of unobservable
inputs when measuring fair value. There were no transfers between the levels of the fair value hierarchy during the periods covered
by the accompanying consolidated financial statements.
Consistent
with the valuation hierarchy contained in ASC 820, we categorized certain of our financial assets and liabilities as follows:
|
|
April 30, 2020
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, related party
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
-
|
|
Notes receivable
|
|
|
118,047
|
|
|
|
-
|
|
|
|
-
|
|
|
|
118,047
|
|
Investments in unconsolidated entities
|
|
|
20,000
|
|
|
|
-
|
|
|
|
-
|
|
|
|
20,000
|
|
Total assets
|
|
$
|
138,047
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
138,047
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable
|
|
$
|
115,745
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
115,745
|
|
Notes payable
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Total liabilities
|
|
$
|
115,745
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
115,745
|
|
|
|
April 30, 2019
|
|
|
|
Total
|
|
|
Level 1
|
|
|
Level 2
|
|
|
Level 3
|
|
Assets
|
|
|
|
|
|
|
|
|
|
|
|
|
Accounts receivable, related party
|
|
$
|
3,446,114
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,446,114
|
|
Investments in unconsolidated entities
|
|
|
207,500
|
|
|
|
-
|
|
|
|
-
|
|
|
|
207,500
|
|
Total assets
|
|
$
|
3,653,614
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
3,653,614
|
|
Liabilities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Convertible notes payable
|
|
$
|
870,567
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
870,567
|
|
Notes payable
|
|
|
2,123,208
|
|
|
|
-
|
|
|
|
-
|
|
|
|
2,123,208
|
|
Total liabilities
|
|
$
|
2,993,775
|
|
|
$
|
-
|
|
|
$
|
-
|
|
|
$
|
2,993,775
|
|
The
Company investments in unconsolidated entities are reported at cost in its consolidated financial statements and are $20,000 and
$207,500 at April 30, 2020 and 2019, respectively. The investments are valued for purposes of this disclosure using unobservable
inputs, since there are no observable market transactions for such investments. Please see Note 8 below for more information about
our investments in unconsolidated entities. The fair values of accounts receivable, related party, and investments in unconsolidated
entities approximate the carrying value of such assets.
At
April 30, 2020 and 2019, convertible notes payable (including current maturities) are reported in our consolidated financial statements
at amortized cost of $150,000 and $905,000, less unamortized debt discount of $34,255 and $34,433, respectively. Our notes and
convertible notes payable are valued for purposes of this disclosure using the multi-nominal valuation model and observable inputs
whenever available. There are no observable market transactions for our notes and convertible notes. Please see Notes 9 and 11
below for more information about our notes and convertible notes payable.
NOTE
4 – EARNINGS PER SHARE
We
calculate basic earnings per share by dividing net earnings available to common shareholders by the weighted average number of
common shares outstanding during the reporting period. Diluted earnings per share is calculated similarly but reflects the potential
impact of outstanding convertible preferred stock, stock warrants and other commitments to issue common stock, including shares
issuable upon the conversion of convertible notes, except where the impact would be anti-dilutive. The calculation of diluted
earnings per share also reflects an adjustment to earnings for the potential interest expense savings, net of applicable income
tax, that would result if the Company’s convertible notes were converted at the beginning of the reporting period.
The
following table sets forth the computations of basic and diluted earnings (loss) per share for the periods indicated:
|
|
Fiscal Year Ended April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Net earnings
|
|
$
|
2,788,605
|
|
|
$
|
21,423,337
|
|
After-tax interest expense adjustment
|
|
|
37,414
|
|
|
|
279,950
|
|
Net earnings, if-converted basis
|
|
$
|
2,826,019
|
|
|
$
|
21,703,287
|
|
Weighted average basic shares
|
|
|
131,472,281
|
|
|
|
80,487,890
|
|
Dilutive securities:
|
|
|
|
|
|
|
|
|
Convertible preferred stock
|
|
|
46,125,389
|
|
|
|
90,914,381
|
|
Convertible notes
|
|
|
39,993,730
|
|
|
|
63,195,608
|
|
Stock options and warrants
|
|
|
22,232,572
|
|
|
|
5,212,360
|
|
Weighted average diluted shares
|
|
|
239,823,972
|
|
|
|
239,810,239
|
|
Earnings per share:
|
|
|
|
|
|
|
|
|
Basic
|
|
$
|
0.02
|
|
|
$
|
0.27
|
|
Diluted
|
|
$
|
0.01
|
|
|
$
|
0.09
|
|
NOTE
5 – NOTES RECEIVABLE
In
the fiscal year 2020, the Company received a promissory note for $58,047 from a prior merchant processor in connection with amounts
owed to the Company. In the fiscal year 2019, the Company received a promissory note for $106,404 from a prior merchant processor
in connection with amounts owed to the Company. The Company and the issuer have been in negotiations aimed at settling this balance.
In March 2020, the Company and the issuer of the note reached an agreement pursuant to which the Company expects to collect $60,000
in full payment of the balance owed to it. In January 2020, the Company recognized an impairment loss of $46,404 in connection
therewith.
In
March and April 2018, the Company entered into certain investment agreements with a third party pursuant to which the Company
loaned an aggregate of $275,000 to the third party. Loans under the related promissory notes accrued at the rate of 12% per annum.
In June 2019, the Company and the third party entered into a loan exchange agreement pursuant to which the Company received a
promissory note for $309,309 in settlement of all amounts owed to the Company under the March and April 2018 loans, including
loan principal of $275,000 and accrued but unpaid interest of $34,309. Loans under the June 2019 promissory note accrue interest
at the rate of 8% per annum. In October 2019, after exhausting all efforts to collect the amounts due pursuant to the June 2019
promissory note, the Company recognized an impairment loss of $309,309 in connection therewith.
In
July 2018, the Company and Hyten Global LLC (“Hyten”) entered into an Asset Purchase Agreement pursuant to which Sharing
Services agreed to purchase certain operating assets from Hyten. In connection with the Asset Purchase Agreement, the Company
had provided secured cash advances in the aggregate amount of $655,789. In September 2018, the Company and Hyten entered into
a Rescission and Mutual Release agreement pursuant to which the parties agreed to terminate the transaction contemplated in the
Asset Purchase Agreement and exchanged customary mutual releases. In addition, in September 2018, Hyten executed a promissory
note in favor of the Company for $655,789 relating to the cash advances received from the Company prior to that date. The note
bears interest at 5%. In April 2019, the Company determined that it is probable the Company will not recover its loan principal
and, accordingly, the Company recognized a provision for uncollectible note receivable of $655,789 in connection therewith.
NOTE
6 – OTHER CURRENT ASSETS
Other
current assets consist of the following:
|
|
As of April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Prepaid expenses
|
|
$
|
404,089
|
|
|
$
|
270,625
|
|
Right to recover asset
|
|
|
76,103
|
|
|
|
65,257
|
|
Employee advances and other
|
|
|
554,787
|
|
|
|
37,428
|
|
|
|
$
|
1,034,979
|
|
|
$
|
373,310
|
|
Prepaid
expenses consist of payments for goods and services (such as trade show expenses and insurance premiums) which are expected to
be consumed in the Company’s operations in the next operating cycle. Right to recover asset is associated with our customers’
right of return and is expected to be recovered in one year or less. As of April 30, 2020, employee advances include $554,630
due from a director in connection with payroll tax obligations associated with the exercise of stock warrants.
NOTE
7 - PROPERTY AND EQUIPMENT
Property
and equipment consist of the following:
|
|
As of April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Furniture and fixtures
|
|
$
|
224,239
|
|
|
$
|
193,737
|
|
Computer equipment and software
|
|
|
155,493
|
|
|
|
91,223
|
|
Leasehold improvements
|
|
|
106,877
|
|
|
|
82,981
|
|
Office equipment
|
|
|
31,652
|
|
|
|
30,601
|
|
Total property and equipment
|
|
|
518,261
|
|
|
|
398,542
|
|
Accumulated depreciation and amortization
|
|
|
(219,878
|
)
|
|
|
(91,018
|
)
|
Property and equipment, net
|
|
$
|
298,383
|
|
|
$
|
307,524
|
|
Depreciation
and amortization expense for the fiscal year ended April 30, 2020 and 2019 was $128,860 and $83,035, respectively, excluding amortization
of right-of-used assets on connection with the Company’s leases.
NOTE
8 – INVESTMENTS IN UNCOLSOLIDATED ENTITIES
At
April 30, 2020 and 2019, investments in consolidated entities is $20,000 and $207,500, respectively. The Company has made from
time to time investments in unconsolidated entities, including in entities engaged in developing, marketing and selling certain
technology, media and travel products; online marketing and direct sales software systems;
technology-based medical cards; and consumer insurance products. The Company
does not, directly or indirectly, hold a controlling financial interest in any of these investees, as the phrase “controlling
financial interest” is defined in GAAP. Thus, the Company does not report these investees on a consolidated basis. In addition,
the Company does not exert influence over the operations or policies of the investees. For example, the Company’s officers,
directors, and management are not involved in the operations or policies of the investees. Accordingly, the Company accounts for
its investment in these investees on the cost basis.
In
the fiscal year ended April 30, 2019, the Company recognized an impairment loss of $1.5 million in connection with its investments
in 212 Technologies, an impairment loss of $1.25 million in connection with its investments in 561 LLC; an impairment loss of
$1.25 million in connection with its investments in America Approved Commercial; an impairment loss of $250,000 in connection
with its investments in Medical Smart Care LLC and an impairment loss of $187,500 in connection with its investments in LEH Insurance
Group LLC as a result of a less than temporary decline in the value of the Company’s investments in these entities. In addition,
in the fiscal year ended April 30, 2020, the Company recognized an impairment loss of $187,500 in connection with its investments
in LEH Insurance Group LLC as a result of a less than temporary decline in the value of the Company’s investment. The Company’s
impairment decisions were based on a number of economic and other factors common to these investees. These factors included, with
respect to all investees named above, (a) failure by the investee to generate sustainable earnings and cash flows within a reasonable
time after commencing operations, (b) failure by the investee to provide timely and accurate financial statements to the Company,
and (c) failure by the investee to comply with certain covenants contained in the investment agreements. In addition, 561 LLC
had never generated sales revenue and 212 Technology had been unable to bring to market commercially acceptable products. Based
on these factors, we believe there is significant uncertainty about the ability of these investees to continue to operate as a
going concern and, accordingly, about the ability of the Company to recover the Company’s investment in the foreseeable
future.
Please
see Note 17 – “Commitments and Contingencies” below for contingencies and other matters associated with the
Company’s investments in unconsolidated entities.
NOTE
9 - NOTES PAYABLE
Notes
payable consisted of the following at April 30, 2019:
Issuance Date
|
|
Maturity Date
|
|
|
|
|
|
November 2018
|
|
July 2019
|
|
|
|
$
|
185,748
|
|
November 2018
|
|
July 2019
|
|
|
|
|
215,960
|
|
December 2018
|
|
December 2019
|
|
|
|
|
698,077
|
|
March 2019
|
|
September 2019
|
|
|
|
|
464,312
|
|
March 2019
|
|
September 2019
|
|
|
|
|
474,603
|
|
March 2019
|
|
September 2019
|
|
|
|
|
464,285
|
|
Total notes payable
|
|
|
|
|
|
|
2,502,985
|
|
Less: debt discount and deferred financing fees
|
|
|
|
|
(379,777
|
)
|
|
|
|
|
|
|
$
|
2,123,208
|
|
In
the fiscal year ended April 30, 2020, the Company paid in full all borrowings under financing arrangements with third-party lenders
in the aggregate amount of $2.5 million, excluding accrued interest payable, which are shown on the table above.
In
November 2018, the Company entered into financing agreements with two third-party lenders pursuant to which the Company agreed
to sell certain future trade receipts, in the aggregate amount of $1,270,000, to the lenders. Net proceeds from these transactions
aggregated $975,000, net of initial financing fees aggregating $25,000 and applicable financing costs calculated at an implied
interest rate of 27%. In December 2018, the Company entered into a Loan Agreement and Promissory Note (the “loan agreement”)
with Global Payroll Gateway pursuant to which the Company borrowed the principal amount of $1,000,000. Borrowings under the loan
agreement were payable, with interest at 10%, in 52 weekly installments. In March 2019, the Company entered into financing agreements
with three third-party lenders pursuant to which the Company agreed to sell certain future trade receipts, in the aggregate amount
of $1,950,000, to the lenders. Net proceeds from these transactions aggregated $1,380,715, net of initial financing fees aggregating
$119,285 and applicable financing costs calculated at an APR rate ranging from 79% to 80%.
Borrowings
under the Company’s financing arrangements generally were secured by a lien on the Company’s accounts receivable,
inventory, and property and equipment to the extent of borrowings outstanding at any point in time. In the fiscal year ended April
30, 2020 and 2019, interest expense associated with the Company’s promissory notes was $333,559 and $348,639, respectively,
and is included in interest expense in our consolidated statements of operations.
NOTE
10 - ACCRUED AND OTHER CURRENT LIABILITIES
Accrued
and other current liabilities consist of the following:
|
|
As of April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Payroll and payroll related
|
|
$
|
645,320
|
|
|
$
|
37,807
|
|
Employee stock warrants liability
|
|
|
661,684
|
|
|
|
-
|
|
Accrued payroll and other taxes
|
|
|
554,630
|
|
|
|
-
|
|
Lease liability, current portion
|
|
|
476,950
|
|
|
|
-
|
|
Accrued shipping and freight
|
|
|
15,777
|
|
|
|
226,695
|
|
Accrued interest payable
|
|
|
15,419
|
|
|
|
139,746
|
|
Other operational accruals
|
|
|
409,389
|
|
|
|
290,887
|
|
|
|
$
|
2,779,169
|
|
|
$
|
695,135
|
|
Employee
stock warrants liability relates to stock warrants granted to directors, employees and consultants at an exercise price indexed
to the market price of the Company’s common stock (please see Note 16 for more details). Lease liability, current portion,
represent obligations due withing one year under operating leases for office space, automobiles, and office equipment. Please
see Note 2 – “Significant Accounting Policies - Lease Accounting”
above for information about the Company’s adoption of ASC Topic 842.
NOTE
11 - CONVERTIBLE NOTES PAYABLE
Convertible
notes payable consists of the following:
|
|
|
|
Conversion Price
|
|
|
As of April 30,
|
|
Issuance Date
|
|
Maturity Date
|
|
(per share)
|
|
|
2020
|
|
|
2019
|
|
October 2017
|
|
October 2022
|
|
$
|
0.15
|
|
|
$
|
50,000
|
|
|
$
|
50,000
|
|
November 2017
|
|
On Demand
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
5,000
|
|
January 2018
|
|
On Demand
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
250,000
|
|
February 2018
|
|
On Demand
|
|
$
|
0.0025
|
|
|
|
-
|
|
|
|
250,000
|
|
March 2018
|
|
On Demand
|
|
$
|
0.01
|
|
|
|
-
|
|
|
|
250,000
|
|
April 2018
|
|
April 2021
|
|
$
|
0.01
|
|
|
|
100,000
|
|
|
|
100,000
|
|
Total convertible notes payable
|
|
|
|
|
|
|
150,000
|
|
|
|
905,000
|
|
Less: unamortized debt discount and deferred financing fees
|
|
|
|
|
|
|
(34,255
|
)
|
|
|
(34,433
|
)
|
|
|
|
|
|
|
|
115,745
|
|
|
|
870,567
|
|
Less: current portion of convertible notes payable
|
|
|
|
|
|
|
90,157
|
|
|
|
855,000
|
|
Long-term convertible notes payable
|
|
|
|
|
|
$
|
25,588
|
|
|
$
|
15,567
|
|
The
Company’s convertible notes are convertible, at the option of the holder, into shares of the Company’s common stock
at the conversion prices shown above. Borrowings on the Company’s convertible notes bear interest at the annual rate of
12%, except as otherwise indicated below.
On
December 6, 2019, the Company and the holder of the Company’s convertible note dated April 13, 2018 (the “April 2018
Note”) entered into an addendum to the underlying promissory note. Pursuant to the addendum, the parties extended the maturity
date of the April 2018 Note to April 13, 2021. In addition, after giving effect to the addendum, the April 2018 Note is non-interest
bearing. All other terms of the April 2018 Note remain unchanged. The Company recorded this transaction as an exchange of debt
instruments with substantially different terms. In connection therewith, the Company recognized a gain on extinguishment of debt
of $13,972. The new debt was recorded net of an initial unamortized debt discount of $13,972, which is being amortized over the
term of the April 2018 Note, as amended.
In
the fiscal year ended April 30, 2020 and 2019, interest expense associated with the Company’s convertible notes was $47,360
and $254,367, respectively. The Company also recognized amortization expense related to the debt discounts and deferred financing
fees in the aggregate amount of $14,151 and $1,154,510 for the fiscal year ended April 30, 2020 and 2019, respectively. These
amounts are included in interest expense in our consolidated statements of operations.
In
November 2018, the holder of a convertible note in the principal amount of $15,000 converted $6,000 of outstanding principal into
1,200,000 shares of the Company’s common stock and, in April 2019, converted $9,000 of outstanding principal and $1,000
of accrued but unpaid interest into 2,000,000 shares of the Company’s common stock. In addition, in
December 2019, the holder of a convertible promissory note converted $28,000 in accrued but unpaid interest into 2,800,000
shares of the Company’s common stock.
As
of April 30, 2018, certain of the Company’s notes had a conversion price based on a discount (39%) from the lowest two (2)
prices for the Company’s common shares during the fifteen (15) trading days prior to conversion. The Company determined
that the conversion feature of certain notes outstanding met the definition of “liability” in accordance with ASC
Topic No. 815, “Derivatives and Hedging - Contracts in Entity’s Own Stock” (“ASC 815”) and,
accordingly, bifurcated the embedded conversion option once each note became convertible, and accounted for it as a derivative
liability. The fair value of the conversion feature was recorded as a debt discount and was amortized into interest expense over
the term of each note. For this purpose, the Company valued the conversion feature using the Binomial option pricing valuation
model. For notes issued during the period from inception (May 5, 2017) to April 30, 2018, the aggregate fair value of the derivative
liability was $28,467,261. Of this amount, $1,199,000 of the value assigned to the derivative liability was recognized as a debt
discount to the notes while the balance of $27,268,261 was recognized as a “day 1” derivative loss.
During
the fiscal year ended April 30, 2019, the Company repaid the convertible notes with a variable conversion rate, a conversion rate
tied to the market price of the Company’s common stock. The remaining convertible notes and warrants outstanding have a
fixed conversion rate and, accordingly, the number of shares issuable upon conversion is fixed. As a result of the repayment,
the Company has recognized a decrease in its derivative liabilities resulting in the beneficial conversion feature associated
with the remaining convertible notes and warrants of $1,187,242 (recognized as an increase to additional paid-in capital) and
a gain on fair value of derivatives liabilities of $20,015,840. Please see Note 12 – “Derivative Liabilities”
below for more information.
NOTE
12 - DERIVATIVE LIABILITIES
The
Company had no derivative liability outstanding at any time during the fiscal year ended April 30, 2020. The Company analyzed
the conversion option for derivative accounting consideration under ASC 815 and determined that the Company’s convertible
notes and stock warrants outstanding at April 30, 2018 should be classified as a liability, under ASC 815, since the conversion
options become effective at issuance and there is no explicit limit to the number of shares issuable upon conversion due to contingencies
affecting the conversion rate. ASC 815 requires that we assess the fair market value of our derivative liabilities at the end
of each reporting period and recognize the change in fair market value (“marked-to-market adjustments”) in measuring
earnings.
The
Company classifies its derivative liabilities under Level 3 of the three-level hierarchy for measuring fair value (please see
Note 3– “Fair Value Measurements of Financial Instruments” above for more details) and uses a multi-nominal
lattice model to calculate the fair value of these liabilities. The multi-nominal lattice model requires six data inputs including:
(1) the exercise or conversion price, (2) the expected term (in years), (3) the expected volatility for the Company’s common
stock, (4) the current stock price, (5) the risk-free interest rate, and (6) the expected dividend yield. Changes to these inputs
could result in a significantly higher or lower fair value measurement.
The
following weighted-average assumptions were used for the period indicated:
|
|
|
Fiscal Year Ended
April 30, 2019
|
|
Expected term (in years)
|
|
|
1.0 – 5.0
|
|
Expected average volatility
|
|
|
107% – 237%
|
|
Risk-free interest rate
|
|
|
1.65% – 2.96%
|
|
Expected dividend yield
|
|
|
-
|
|
The
following table summarizes the changes in the Company’s derivative liabilities:
Fair Value Measurements Using Significant Unobservable Inputs (Level 3)
|
Balance at April 30, 2018
|
|
$
|
30,488,655
|
|
Additions of new derivatives recognized as debt discounts
|
|
|
325,000
|
|
Additions of new derivatives recognized as loss on derivatives
|
|
|
679,032
|
|
Reclassifications of derivatives due to tainted instruments
|
|
|
258,132
|
|
Change in fair value of the derivative
|
|
|
(10,547,737
|
)
|
Reclassification of derivative to additional paid-in capital
|
|
|
(1,187,242
|
)
|
Change in derivative liabilities recognized as gain on derivative
|
|
|
(20,015,840
|
)
|
Balance at April 30, 2019
|
|
$
|
-
|
|
The
following table summarizes the gain on derivative liability included in our consolidated statements of operations for the period
indicated:
|
|
Fiscal Year Ended
April 30, 2019
|
|
Day one loss due to derivative liabilities on convertible notes payable and warrants
|
|
$
|
(679,032
|
)
|
Change in derivative liabilities
|
|
|
20,015,840
|
|
Gain (loss) from marked-to-market adjustments
|
|
|
10,556,846
|
|
Net gain (loss) on derivative liabilities
|
|
$
|
29,893,654
|
|
NOTE
13 – LEASES
The
Company leases space for its corporate headquarters, and additional office and warehouse space, under lease agreements classified
as “operating leases’” as defined in ASC Topic 842. The Company’s real estate lease agreements have remaining
terms varying from one to two years, offer the Company customary renewal options, and contain provisions for customary common
area maintenance (CAM) assessments by the lessor. Please see Note 2 – “Significant Accounting Policies” –
“Property and Equipment” and “Lease Accounting” above for more information.
The
following information pertains to the Company’s leases as of the balance sheet dates indicated:
Assets
|
|
Classification
|
|
|
|
As of April 30,
2020
|
|
Operating leases
|
|
Right-of-use assets, net
|
|
|
|
$
|
800,381
|
|
Total leased assets
|
|
|
|
|
|
$
|
800,381
|
|
|
|
|
|
|
|
|
|
|
Liabilities
|
|
|
|
|
|
|
|
|
Operating leases
|
|
Accrued and other current liabilities
|
|
|
|
$
|
476,950
|
|
Operating leases
|
|
Lease liability, long-term
|
|
|
|
|
343,948
|
|
Total lease liability
|
|
|
|
|
|
$
|
820,898
|
|
The
following information pertains to the Company’s leases for the periods indicated:
|
|
|
|
Fiscal Year Ended April 30,
|
|
Lease cost
|
|
Classification
|
|
2020
|
|
|
2019
|
|
Operating lease cost
|
|
General and administrative expenses
|
|
$
|
637,876
|
|
|
$
|
468,954
|
|
Operating lease cost
|
|
Depreciation and amortization
|
|
|
-
|
|
|
|
-
|
|
Operating lease cost
|
|
Interest expense, net
|
|
|
-
|
|
|
|
-
|
|
Total lease cost
|
|
|
|
$
|
637,876
|
|
|
$
|
468,954
|
|
The
Company’s lease liability is payable as follows:
Fiscal year ended April 30,
|
|
|
|
2021
|
|
$
|
476,950
|
|
2022
|
|
|
276,595
|
|
2023
|
|
|
50,630
|
|
2024
|
|
|
16,723
|
|
Thereafter
|
|
|
-
|
|
Total lease liability
|
|
$
|
820,898
|
|
NOTE
14 – INCOME TAXES
The
Company is an emerging growth company and, prior to its fiscal quarter ended October 31, 2018, had not generated earnings from
its operations or pre-tax earnings. During its fiscal year ended April 30, 2018 and 2019, the Company had a consolidated operating
loss of $6.0 million and $1.0 million, respectively. During the fiscal year ended April 30, 2020, the Company’s consolidated
operating earnings were $9.7 million. The Company believes that it is probable it will utilize its available net operating losses
entirely in the foreseeable future. During the fiscal year ended April 30, 2020, the Company recognized a current provision for
income taxes of $2.1 million and a deferred income tax benefit of $1.6 million. Prior to the fiscal year ended April 30, 2020,
the Company had not recognized a provision for (benefit from) income taxes.
In
December 2017, the U.S. enacted comprehensive amendments to the Internal Revenue Code of 1986 (“U.S. Tax Reform of 2017”).
Among other things, U.S. Tax Reform of 2017 reduced the federal statutory tax rate for corporate taxpayers to 21% and otherwise
modified corporate tax rules in significant ways. The U.S. Tax Reform of 2017 did not otherwise have a material impact on the
Company’s financial statements.
For
the fiscal year ended April 30, 2020, our income tax rate reconciliation is as follows:
Federal statutory rate
|
|
|
21.0
|
%
|
State income taxes and franchise tax
|
|
|
3.5
|
%
|
Net operating loss utilization and other
|
|
|
(9.7
|
)%
|
Effective tax rate
|
|
|
14.8
|
%
|
For
the fiscal year ended April 30, 2020, our consolidated provision for (benefit from) income taxes is as follows:
Current:
|
|
|
|
|
Federal
|
|
$
|
2,020,305
|
|
State
|
|
|
113,714
|
|
Total current
|
|
|
2,134,019
|
|
Deferred:
|
|
|
|
|
Federal
|
|
|
(1,649,018
|
)
|
State
|
|
|
-
|
|
Total deferred
|
|
|
(1,649,018
|
)
|
Total consolidated income tax provision
|
|
$
|
485,001
|
|
As
of April 30, 2020, our deferred tax asset (liability) is as follows:
Gross deferred tax asset:
|
|
|
|
Share-based compensation
|
|
$
|
1,098,622
|
|
Accruals and reserves not currently deductible
|
|
|
550,396
|
|
Total deferred tax asset
|
|
|
1,649,018
|
|
Total deferred tax liability
|
|
|
-
|
|
Total consolidated deferred tax asset
|
|
$
|
1,649,018
|
|
NOTE
15 - RELATED PARTY TRANSACTIONS
Alchemist
Holdings, LLC
In
connection with the Company’s acquisition of Total Travel Media, Inc. in May 2017, the Company issued 7,500,000 shares of
its Series B preferred stock and 7,500,000 shares of its Class B common stock to Alchemist Holdings, LLC (“Alchemist”),
an entity which was under the operational control of the then Chairman of our Board of Directors. In connection with the Company’s
acquisition of Four Oceans Holdings, Inc. in September 2017, the Company issued 50,000,000 shares of its Series A preferred stock
to Alchemist. Such shares of Series A preferred stock have since been converted to shares of the Company’s Class A common
stock. The information contained in Note 1 of Notes to the Consolidated Financial Statements located in ITEM 8 – Financial
Statements and Supplementary Data in our Annual Report on Form 10-K for the fiscal year ended April 30, 2019 is incorporated herein
by reference.
Bear
Bull Market Dividends, Inc.
In
connection with the Company’s acquisition of Total Travel Media, Inc., the Company issued 2,500,000 shares of its Series
B preferred stock and 2,500,000 shares of its Class B common stock to Bear Bull Market Dividends, Inc. In connection with the
Company’s acquisition of Four Oceans Holdings, Inc., the Company issued 20,000,000 shares of its Series A preferred stock
to Bear Bull Market Dividends, Inc.
Related
Party Sublease
The
Company subleases warehouse and office space from Alchemist. During the fiscal years ended April 30, 2020 and 2019, rent expense
associated with such sublease agreement was $91,980 and $8,184, respectively.
Accounts
Receivable, Related Party
As
disclosed earlier, in January 2019, the Company became aware of an unliquidated amount of potential liability arising from a series
of cash advance loan transactions (the “Loan Transactions”) entered into by eight different lending sources and a
Related Party entity (the “debtor entity”) at the time owned and/or controlled by a former Company officer. Without
the knowledge of the Company and in contravention of the express provisions of both the Company’s Bylaws and the controlling
Nevada Revised Statutes, this former officer also purported to obligate the Company (and two of the Company’s affiliates)
to repay the amounts owed by the debtor entities under the Loan Transactions. The Company has settled all the debt associated
with the Loan Transactions at a substantial discount from the amounts alleged by the holders of such debt. Additionally, in February
2019, the Company, the debtor entity, and the former Company officer entered into a comprehensive Settlement Agreement (the “February
2019 Settlement Agreement”), secured by substantial assets, pursuant to which the debtor entity and the former Company officer
became obligated jointly and severally to repay the Company the sums expended by the Company in the resolution of the Loan Transactions.
The Company had recorded an accounts receivable of $3.4 million from the debtor entity and the former Company officer in connection
therewith. This amount was reported in accounts receivable, related party in our consolidated balance sheets.
In
February 2020, the Company, the debtor entity, and the former Company officer entered into a Settlement Accommodation Agreement
(the “Accommodation Agreement”) pursuant to which the debtor entity and the former Company officer agreed to transfer
to the Company 22,683,864 shares of the Company’s common stock held by the debtor entity, in settlement of the obligations
to the Company under the February 2019 Settlement Agreement. In addition, the Company, the debtor entity, and the former Company
officer entered into a Securities Escrow Agreement (the “Escrow Agreement”). Under the terms of the Escrow Agreement,
the Company acquired control of the 22,683,864 shares of the Company’s common stock to be transferred to the Company, which
shares are to be transferred to the Company at a time that the Company, in its sole discretion, decides. In connection with Accommodation
Agreement and Escrow Agreement, the Company recognized a deemed dividend in the amount of $2.6 million for the difference between
the fair value of the 22,683,864 shares of the Company’s common stock on the effective date of such agreements, and the
accounts receivable settled.
Under
the terms of the Accommodation Agreement discussed in the preceding paragraph, the Company will also receive 15,625,000 shares
of its common stock to offset certain legal and other expenses incurred by the Company in connection with various related-party
legal claims. Under the terms of the Escrow Agreement discussed in the preceding paragraph, such shares are to be transferred
to the Company at a time that the Company, in its sole discretion, decides. The Company has recognized a deemed dividend in the
amount of $937,500 for the difference between the fair value of such 15,625,000 shares of the Company’s common stock and
the settlement amount. In addition, under the terms of the Accommodation Agreement, the Company awarded to the debtor entity,
a put option to sell to the Company up to 5.0 million shares of the Company’s common stock held by the debtor entity at
$0.10 per share, subject to certain conditions. In connection therewith, the Company recorded a deemed dividend in the amount
of $177,880 for the fair value of the put option.
See
Note 17 – “Commitments and Contingencies” below for more information about our related parties.
NOTE
16 - STOCKHOLDERS’ EQUITY (DEFICIT)
Preferred
Stock
The
Company’s Board has authorized the issuance of up to 200,000,000 shares of preferred stock, par value of $0.0001 per share.
The Board may divide this authorization into one or more series, each with distinct powers, designations, preferences, and rights.
Series
A Convertible Preferred Stock
The
Company’s Board has authorized the issuance of up to 100,000,000 shares of Series A Convertible
Preferred Stock (the “Series A preferred stock”). Shares of our Series A preferred stock are senior in rank
to shares of our Series C preferred stock, but junior to shares of our Series B preferred stock. The affirmative vote of the holders
of 86% of the issued and outstanding shares of our Series A preferred stock is required for the Board: (i) to declare dividends
upon shares of common stock unless, with respect to cash dividends, the shares of our Series A preferred stock are to receive
the same dividend as the common shares, on an as converted basis; (ii) to redeem the shares of our Series A preferred stock at
a redemption price of $0.001 per share; (iii) to authorize or issue additional or other capital stock that is junior or equal
in rank to shares of our Series A preferred stock with respect to the preferences as to distributions and payments upon the liquidation,
dissolution, or winding up of the Company; and (iv) to amend, alter, change, or repeal any of the powers, designations,
preferences, and rights of our Series A preferred stock. Upon the dissolution, liquidation, or winding up of the Company, whether
voluntary or involuntary, the holders of the Series A preferred stock are entitled to receive out of the assets of the Company
the sum of $0.001 per share before any payment or distribution shall be made on the shares of common stock, or any other class
of capital stock ranking junior to the Series A Preferred Stock. For a period of 10 years from the date of issuance, the holders
of the Series A preferred stock may elect to convert each share of the Series A preferred stock into one share of the Company’s
common stock. Each share of our Series A preferred stock is entitled to one vote when voting as a class or together with the shares
of common stock.
In
September 2017, the Company issued 75,000,000 shares of its Series A preferred stock
in connection with the acquisition of Four Oceans Holdings, Inc. The Company recognized a deemed dividend of $18,750,000 in connection
to the acquisition of Four Oceans.
During
the fiscal year ended April 30, 2020 and 2019, stockholders converted an aggregate of 10,400,000 shares and 51,315,790 shares,
respectively, of the Company’s Series A preferred stock into an equal number of shares of the Company’s common stock.
During the fiscal year ended April 30, 2019, the Company issued 7,500,000 shares of its Series A preferred stock in connection
with purchases of equity interest in unconsolidated entities, which were valued at a fair
market value of $1,875,000.
Series
B Convertible Preferred Stock
The
Company’s Board has authorized the issuance of up to 10,000,000 shares of Series B Convertible
Preferred Stock (the Series B preferred stock”). Shares of our Series B preferred stock are senior in rank to shares
of our Series A and Series C preferred stock. The affirmative vote of the holders of 86% of the issued and outstanding shares
of our Series B preferred stock is required for the Board: (i) to declare dividends upon shares of common stock unless, with respect
to cash dividends, the shares of our Series B preferred stock are to receive the same dividend as the common shares, on an as
converted basis; (ii) to redeem the shares of our Series B preferred stock at a redemption price of $0.001 per share; (iii) to
authorize or issue additional or other capital stock that is senior, junior or equal in rank to shares of our Series B preferred
stock with respect to the preferences as to distributions and payments upon the liquidation, dissolution, or winding up of the
Company; and (iv) to amend, alter, change, or repeal any of the powers, designations, preferences, and rights of the Series B
preferred stock. Upon the dissolution, liquidation, or winding up of the Company, whether voluntary or involuntary, the holders
of the Series B preferred stock are entitled to receive out of the assets of the Company the sum of $0.001 per share before any
payment or distribution shall be made on the shares of common stock, or any other class of capital stock of the Company ranking
junior to the Series B preferred stock. For a period of 10 years from the date of issuance, the holders of the Series B preferred
stock may elect to convert each share of Series B preferred stock into one share of the Company’s common stock. Each share
of our Series B preferred stock is entitled to one vote when voting as a class, and to one thousand votes when voting together
with shares of our common stock.
In
May 2017, the Company issued 10,000,000 shares of its Series B preferred stock in
connection with the acquisition of Total Travel Media, Inc.
Series
C Convertible Preferred Stock
The
Company’s Board has authorized the issuance of up to 10,000,000 shares of Series C Convertible Preferred Stock (the Series
C preferred stock”). Shares of our Series C preferred stock are junior in rank to the Series A and Series B preferred stock.
The affirmative vote of the holders of 86% of the issued and outstanding shares of our Series C preferred stock is required for
the Board: (i) to declare dividends upon shares of common stock unless, with respect to cash dividends, the shares of our Series
C preferred stock are to receive the same dividend as the common shares, on an as converted basis; (ii) to redeem the shares of
Series C preferred stock at a redemption price of $0.001 per share; (iii) to authorize or issue additional or other capital stock
that is junior or equal in rank to our Series C preferred stock with respect to the preferences as to distributions and payments
upon the liquidation, dissolution, or winding up of the Company; and (iv) to amend, alter, change, or repeal any of the powers,
designations, preferences, and rights of the Series C preferred stock. Upon the dissolution, liquidation, or winding up of the
Company, whether voluntary or involuntary, the holders of the Series C preferred stock are entitled to receive out of the assets
of the Company the sum of $0.001 per share before any payment or distribution shall be made on the shares of common stock, or
any other class of capital stock of the Company ranking junior to the Series C preferred stock. For a period of 10 years from
the date of issuance, the holders of the Series C preferred stock may elect to convert each share of Series C preferred stock
into one share of the Company’s common stock. Each share of our Series C preferred stock is entitled to one vote when voting
as a class or together with shares of common stock.
During
the fiscal year ended April 30, 2020 and 2019, the Company issued 20,000 shares and 170,000 shares, respectively, of its Series
C preferred stock in exchange for cash in the amount of $5,000 and $42,500, respectively, in connection with stock subscription
agreements in the ordinary course of its business. During the fiscal year ended April 30, 2020 and 2019, holders of 50,000 shares
and 600,000 shares, respectively, of the Company’s Series C preferred stock converted their holdings into an
equal number of shares of the Company’s common stock.
Common
Stock
The
Company’s Board has authorized the issuance of up to 500,000,000 shares of common stock (Class A) and up to 10,000,000 shares
of common stock (Class B), each with a par value of $0.0001 per share. Holders of our common stock are entitled to dividends,
subject to the rights of the holders of other classes of capital stock outstanding having priority rights with respect to dividends.
Our classes of common stock have the same rights, except that the holders of our Class B common stock have the right to elect
a majority of our Board, while the holders of our Class A common stock together with our Series A preferred stock, Series B preferred
stock and Series C preferred stock have the right to elect the rest of the directors. References to our “common stock”
throughout this report include our Class A common stock and Class B common stock, unless otherwise indicated or the context otherwise
requires.
During
the fiscal year ended April 30, 2020 and 2019, the Company issued 30,000 shares and 870,000 shares, respectively, of its Class
A common stock for cash in the amount of $7,500 and $217,500, respectively in connection with stock subscription agreements
in the ordinary course of its business. In addition, in the fiscal year ended April
30, 2020 and 2019, the Company issued 215,325 shares and 449,851 shares, respectively,
in exchange for consulting services with fair market value of $57,000 and $119,000, respectively. In the fiscal year ended April
30, 2018, the Company issued 10,000,000 shares of its Class B common stock in connection with the acquisition of Total Travel
Media.
In
the fiscal year ended April 30, 2020 and 2019, holders of 10,400,000 shares and 51,315,790 shares, respectively, of
the Company’s Series A preferred stock, and holders of 50,000 shares and 600,000 shares, respectively, of the Company’s
Series C preferred stock converted their holdings into an equal number of shares of the
Company’s common stock.
In
the fiscal year ended April 30, 2020 and 2019, holders of the Company’s convertible promissory notes converted $28,000 and
$16,000, respectively, in notes principal and/or accrued interest into 2,800,000 shares and 3,200,000 shares, respectively, of
the Company’s Class A common stock, pursuant to the terms of the underlying debt instruments.
In
the fiscal year ended April 30, 2020 and 2019, the Company issued, in the aggregate, 10,000,000 shares and 21,470,620 shares,
respectively, of its Class A common stock to officers and/or directors, at an exercise price of $0.0001 per share, upon the exercise
of derivative instruments granted in conjunction with employment agreements disclosed previously. In addition, in the fiscal year
ended April 30, 2019, the Company issued 800 shares of its Class A common stock in connection with stock warrants exercised, at
an exercise price of $0.25 per share.
In
addition, in the fiscal year ended April 30, 2020 and 2019, the Company repurchased in private transactions (and retired) 1,500,000
shares and 30,000,000 shares, respectively, of its Class A common stock.
Stock
Options
In
March 2018, the Company issued fully vested options to purchase up to 3,000,000 shares of its common stock to its Chief Financial
Officer in connection with his employment agreement. The stock options had an exercise price of $0.0001 per share and were exercised
in the fiscal year ended April 30, 2019.
Stock
Warrants
In
March 2018, the Company issued fully-vested warrants to purchase up to 5,000,000 shares of its Series A preferred stock and, in
January 2019, fully-vested warrants to purchase up to 13,470,620 shares of the its Series A preferred stock to its President and
Chief Executive Officer in connection with his employment agreement, as disclosed previously. All the stock warrants had an exercise
price of $0.0001 per share and were exercised in the fiscal year ended April 30, 2019. In addition, the resulting shares of Series
A preferred stock were converted into and equal number of the Company’s common stock.
In
the fiscal year ended April 30, 2019, the Company sold 870,000 fully vested five-year warrants to purchase an equal number of
shares of its common stock in connection with stock subscription agreements. The exercise price for these warrants is equal to
50% of the average closing bid price for the Company’s common stock for the 20-day trading period immediately prior to exercise.
In
the fiscal year ended April 30, 2020, the Company issued stock warrants to purchase, in the aggregate, up to 32,000,000 shares
of the its common stock, with an aggregate fair value of $6.8 million, to certain directors, employees and a consultant. These
stock warrants have an exercise price equal to par ($0.0001 per share). In the fiscal year ended April 30, 2020, the Company issued
10,000,000 shares of its common stock to one director upon the exercise of warrants. In the fiscal year ended April 30, 2019,
the Company issued warrants to purchase, in the aggregate, up to 160,000 shares of the its common stock to two consulting firms
in exchange for consulting services with an aggregate fair value of $38,980.
In
the fiscal year ended April 30, 2020 and 2019, the Company issued fully vested warrants to purchase up to 628,800 shares and 1,582,600
shares, respectively, of its common stock to members of its independent sales force, with a fair value of $95,445 and $267,620,
respectively. The warrants are exercisable for a period of two years from the issuance date, subject to certain default provisions,
at the exercise price of $0.25 per share. In the fiscal year ended April 30, 2019, the Company issued 800 shares of its common
stock to members of its independent sales force in connection with stock warrants exercised.
The
following table summarizes the activity relating to the Company’s stock warrants:
|
|
Number of
Warrants
|
|
|
Weighted Average
Exercise Price
|
|
|
Weighted Average
Remaining Term
|
|
Outstanding at April 30, 2018
|
|
|
6,643,333
|
|
|
$
|
0.04
|
|
|
|
8.7
|
|
Granted
|
|
|
16,083,220
|
|
|
|
0.31
|
|
|
|
2.6
|
|
Exercised
|
|
|
(18,471,420
|
)
|
|
|
-
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at April 30, 2019
|
|
|
4,255,133
|
|
|
$
|
0.24
|
|
|
|
2.4
|
|
Granted
|
|
|
32,628,800
|
|
|
|
0.005
|
|
|
|
4.4
|
|
Exercised
|
|
|
(10,000,000
|
)
|
|
|
0.0001
|
|
|
|
-
|
|
Expired or forfeited
|
|
|
-
|
|
|
|
-
|
|
|
|
-
|
|
Outstanding at April 30, 2020
|
|
|
26,883,933
|
|
|
$
|
0.04
|
|
|
|
4.2
|
|
The
following table summarizes additional information relating to stock warrants outstanding and exercisable:
Warrants Outstanding at April 30, 2020
|
Warrants Outstanding
|
|
Warrants Exercisable
|
|
|
|
Weighted
Average Remaining
|
|
|
Weighted
Average
|
|
|
|
|
|
Weighted
Average
|
|
Number of
Shares
|
|
Contractual
life (in years)
|
|
|
Exercise
Price
|
|
|
Number of
Shares
|
|
|
Exercise
Price
|
|
22,000,000
|
|
|
4.7
|
|
|
$
|
0.0001
|
|
|
|
22,000,000
|
|
|
$
|
0.0001
|
|
2,180,000
|
|
|
3.1
|
|
|
$
|
0.04
|
|
|
|
2,180,000
|
|
|
$
|
0.04
|
|
2,270,600
|
|
|
0.9
|
|
|
$
|
0.25
|
|
|
|
2,270,600
|
|
|
$
|
0.25
|
|
100,000
|
|
|
1.9
|
|
|
$
|
3.00
|
|
|
|
100,000
|
|
|
$
|
3.00
|
|
333,333
|
|
|
2.4
|
|
|
$
|
0.15
|
|
|
|
333,333
|
|
|
$
|
0.15
|
|
26,883,933
|
|
|
|
|
|
|
|
|
|
|
26,883,933
|
|
|
|
|
|
The
tables above do not include stock warrants issued to employees and consultants to purchase up to 11,575,000 shares of the Company’s
common stock that have variable exercise prices and vest over time, including stock warrants to purchase up to 1,000,000 shares
common stock that are fully vested at April 30, 2020. As of April 30, 2020, the Company has recognized a liability of $661,684
in connection with these stock warrants.
NOTE
17 - COMMITMENTS AND CONTINGENCIES
Contingencies
Acquisition-related
Contingencies
In
October 2017, the Company entered into a Share Exchange Agreement pursuant to which it acquired a 25% interest in 561 LLC in exchange
for 2,500,000 shares of its Series A preferred stock with a deemed value of $0.25 per share. Under the terms of the Share Exchange
Agreement, in May 2018, the Company increased its cumulative equity interest in 561 LLC to 40% in exchange for 2,500,000 shares
of its Series A preferred stock. Under the terms of the Share Exchange Agreement,
the sellers shall be entitled to an additional 2,500,000 shares of our Series A preferred
stock when both of the following conditions have been met: (a) one year has passed from
the Closing Date and (b) the closing bid price of the Company’s common stock equals or exceeds $5.00 per share,
as reported by OTC Markets. In accordance with GAAP, the Company has not recorded a liability in connection with this contingency.
In
October 2017, the Company entered into a Share Exchange Agreement pursuant to which it acquired a 25% interest in America Approved
Commercial LLC (“AAC”) in exchange for 2,500,000 shares of our Series A preferred stock with a deemed value of $0.25
per share. Under the terms of the Share Exchange Agreement, in May 2018, the Company increased its cumulative equity interest
in AAC to 40% in exchange for 2,500,000 shares of its Series A preferred stock. As of April 30, 2019, the Company had issued 5,000,000
shares of its Series A preferred stock (with a deemed value of $1,250,000) in connection with its acquisition of AAC. Under the
terms of the Share Exchange Agreement, the
sellers shall be entitled to an additional 2,500,000 shares of the Company’s Series A preferred stock when both of
the following conditions have been met: (a) one year has passed from the Closing
Date and (b) the closing bid price of the Company’s common stock equals or exceeds $5.00 per share, as reported by
OTC Markets. In accordance with GAAP, the Company has not recorded a liability in connection with this contingency.
As
of September 16, 2019, the Company and 212 Technologies, LLC (“212 Technologies”) entered into a Release and Settlement
Agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the parties: (i) rescinded a certain
“Stakeholder & Investment Agreement” dated May 21, 2017 (resulting in the return of 5,628,750 shares of the Company’s
Series A Preferred Stock by 212 Technologies and the return of a 24% ownership stake in 212 Technologies by the Company) and (ii)
terminated a certain “Software License Agreement” dated June 12, 2018 (the “SLA”) by and between 212 Technologies
and Elepreneurs, LLC, a wholly owned subsidiary of the Company (“Elepreneurs”). In connection with the Settlement
Agreement, Elepreneurs agreed to pay 212 Technologies the amount of $425,000 and to dismiss with prejudice a lawsuit it had previously
filed concerning the functionality of the mobile application produced by 212 Technologies under the SLA, and the parties reached
mutually accommodating terms and resolved all issues between their respective companies. The Company recognized a loss of $425,000
in connection with the Settlement Agreement. Please see Note 19 for more information.
Legal
Proceedings – Related-Party Matters and Settlement Liability
On
July 26, 2019, the Company and certain of its subsidiaries entered into a Settlement Agreement (the “July 26 Agreement”)
with Company co-founder and former consultant Robert Oblon (“Oblon”). Pursuant to the July 26 Agreement and in compromise
of a dispute concerning a prior contractual obligation and various competing claims, the Company agreed to pay Oblon the aggregate
amount of $2.2 million, payable in 96 equal semi-monthly installments. On August 30, 2019, the Company ceased making the installment
payments and filed a lawsuit against Oblon claiming, among other things, Oblon’s breach of contract related to the July
26 Agreement. During the fiscal year ended April 30, 2020, the Company made payments under the July 26 Agreement of $235,000.
Effective as of February 28, 2020, the Company and the relevant subsidiaries, Oblon, certain officers and directors of the Company,
and certain other corporate parties entered into a Settlement Agreement pursuant to which the relevant parties agreed to settle
all prior disputes among them and the Company and Oblon terminated the July 26 Agreement. For the fiscal year ended April 30,
2020, the Company recognized expenses associated with settlement of several legal disputes, including the matter discussed in
the preceding paragraph. These expenses include a loss of $2.7 million from the settlement of these matters.
Effective
as of February 28, 2020, the Company and the relevant subsidiaries; Jordan Brock (“Brock”), a Co-Founder of the Company;
Robert Oblon; certain officers and directors of the Company; and certain other corporate parties entered into a Multi-Party Settlement
Agreement pursuant to which the foregoing parties agreed to settle all prior disputes among them. In addition, effective February
29, 2020, the Company, Alchemist and Brock entered into a Settlement Accommodation Agreement and an amendment to a previous founder’s
agreement pursuant to which the Company agreed to pay to Brock the sum of $1.4 million over time, and the Company recognized a
settlement liability for that amount. See Note 15 – “Related Party Transactions” above for more information.
As
of April 30, 2020, the Company has a remaining settlement liability of $2,620,931 in connection with all matters discussed in
the preceding two paragraphs.
Legal
Proceedings – Other Matters
The
Company from time to time is involved in various claims and lawsuits incidental to the conduct of its business in the ordinary
course. We do not believe that the ultimate resolution of these matters will have a material adverse impact on our consolidated
financial position, results of operations or cash flows.
(i)
Cause No. 416-01969-2019; Larry Thompson, Sonya “Taylor” Thompson and Taylor Made Enterprises, Inc. v. Sharing
Services Global Corporation f/k/a Sharing Services, Inc., filed in the 416th Judicial District of Collin County, Texas. On
April 10, 2019, Larry Thompson, Sonya “Taylor” Thompson and Taylor Made Enterprises, Inc. filed a lawsuit against
the Company, alleging they were due compensation as contractors on an oral contract. The Plaintiffs had signed a written contract
with the Company that expired on November 30, 2018. A settlement was reached in this matter and the lawsuit was dismissed on October
3, 2019.
(j)
Cause No. 296-02516-2019; Elepreneur, LLC and Elevacity Global LLC v. Larry Thompson, Sonya “Taylor” Thompson and
Taylor Made Enterprises, Inc., filed in the 296th Judicial District of Collin County, Texas. On May 8, 2019, Elevacity
and another of the Company’s subsidiaries, Elepreneur, LLC (“Elepreneur”) filed a lawsuit against Larry Thompson,
Sonya “Taylor” Thompson and Taylor Made Enterprises, Inc. for disparagement of one of Elevacity’s products and
the interference of Elevacity and Elepreneur’s distribution and sale of products. A settlement was reached in this matter
and the lawsuit was dismissed on October 3, 2019.
(k)
Case No. 4:19-cv-00386; Sharing Services Global Corporation, f/k/a Sharing Services, Inc. v. Taylor Made Enterprises, Inc.,
filed in the United States District Court for the Eastern District of Texas. On May 29, 2019, the Company filed a lawsuit in federal
court asserting claims for violations of the Lanham Act and related claims arising from the Defendant’s claims relating
to the trademark Elevate Pink™. A settlement was reached in this matter and the lawsuit was dismissed on October 3, 2019.
(l)
Opposition No. 91249474; Sharing Services IP Holdings, LLC and Sharing Services Global Corporation v. Taylor Made Enterprises,
Inc. On July 10, 2019, SHRG IP Holdings, LLC (“SHRG IP”) a subsidiary of the Company, and the Company filed a
trademark opposition with the United States Patent and Trademark Office, relating to the pending registration of certain trademarks
by Taylor Made Enterprises, Inc. due to the Company’s pending trademark applications for Elevate Pink™. A settlement
was reached in this matter and a Withdrawal of Notice of Opposition was filed with the USPTO Trademark Trial and Appeal Board
on October 2, 2019.
(m)
Cause No. 416-02428-2019; Sharing Services Global Corporation, f/k/a Sharing Services, Inc. v. XIP Technologies, LLC, pending
in the 416th Judicial District of Collin County, Texas. On May 6, 2019, the Company filed a lawsuit against XIP Technologies,
LLC to recover money held by XIP Technologies, LLC that was owed to the Company. The Company obtained a writ of garnishment against
a third-party holding funds for XIP Technologies, LLC. XIP Technologies, LLC has filed an answer denying the claims asserted against
it. A settlement was reached in this matter and, upon final payment of the amounts due to the Company under the Settlement Agreement,
the lawsuit will be dismissed.
(n)
Cause No. 296-03925-2019; Elepreneur, LLC v. 212 Technologies, LLC, filed in the 296th Judicial District of
Collin County, Texas. On July 23, 2019, Elepreneur filed a lawsuit against 212 Technologies, LLC for issues arising from a software
license agreement. A settlement was reached in this matter and the lawsuit was dismissed on March 23, 2020.
(o)
Cause No. 296-03589-2019; Pruvit Ventures, Inc. v. Elevacity, LLC, pending in the 296th Judicial District of
Collin County, Texas. On July 3, 2019, Pruvit Ventures, Inc. filed a lawsuit against Elevacity, alleging a breach of contract
claim. Elevacity has denied the claim of breach contract.
(p)
Cause No. 219-04726-2019; Sharing Services Global Corporation v. Kenyatto M. Jones, Bear Bull Market Dividends, Inc. and Research
and Referral, BZ, filed in the 219th Judicial District of Collin County, Texas. On August 22, 2019, the Company
filed a lawsuit against Kenyatto M. Jones, Bear Bull Market Dividends, Inc. and Research and Referral, BZ for breach of contract,
statutory fraud in a stock transaction, and violations of the Texas Securities Act. On April 13, 2020, the court issued a Final
Default Judgment in favor of the Company finding Research and Referral, BZ (“R&R”) liable for the Company’s
claims of fraud in the inducement and statutory fraud in a stock transaction. Further, the court ordered that the stock transaction
between the Company and R&R be rescinded and the Company’s stock transferred in such transaction be returned to the
Company. Due to the pending lawsuits in Nevada, described below, the Company elected to dismiss its claims against Kenyatto M.
Jones and Bear Bull Market Dividends, Inc. without prejudice in Texas.
(i)
Case No. A-19-802861-B; Sharing Services Global Corporation v. Bear Bull Market Dividends, Inc., Alchemist Holdings, LLC and
Kenyatto M. Jones, pending in the District Court of Clark County, Nevada. On October 1, 2019, the Company filed suit against
two shareholders, Bear Bull Market Dividends, Inc. and Alchemist Holdings, LLC, and the key principal of Bear Bull Market Dividends,
Inc., Kenyatto M. Jones, concerning an amended certificate of designation filed by the Company, and for allegations of self-dealing
by the two shareholders. An entry of default was made against two of the defendant shareholders as well as Mr. Jones, as a key
principal. This matter remains pending.
(j)
Case No. A-20-811265-C; Sharing Services Global Corporation v. Bear Bull Market Dividends, Inc., Research and Referral, BZ
and Kenyatto M. Jones, pending in the District Court of Clark County, Nevada. On February 27, 2020, the Company filed suit
against two shareholders, Bear Bull Market Dividends, Inc. and Research and Referral BZ, as well as a key principal of Bear Bull
Market Dividends, Inc., Kenyatto M. Jones, concerning breach of contract, fraud, violations of state securities laws and alter
ego relating to a stock exchange/transfer transaction, involving the Company’s stock. An entry of default was made against
the two shareholders and key principal Jones and the matter remains pending.
(k)
Cause No. 366-04941-2019; Sharing Services Global Corporation, Elepreneurs U.S., LLC and Elevacity, LLC v. Robert Oblon,
filed in the 366th Judicial District of Collin County, Texas. On August 30, 2019, the Company and its affiliated entities
filed a lawsuit against Robert Oblon for breach of contract, tortious interference with business relationships, and misappropriation
of trade secrets, and sought injunctive relief. A settlement was reached in this matter and the lawsuit was dismissed on March
2, 2020. As part of the settlement, the Company agreed to pay amounts that were due to Oblon under a prior settlement agreement
in the approximate amount of $2,000,000, to be paid in installments through June 1, 2020. The Company completed its final payment
obligation in accordance with the settlement agreement.
(l)
Cause No. 380-01007-2020; Elepreneurs Holdings, LLC, d/b/a Elepreneur, LLC v. Carissa Rogers and Barbie Williams, filed
in the 380th Judicial District of Collin County, Texas. On February 20, 2020, Elepreneurs Holdings, LLC filed a lawsuit
against two of its former distributors for breach of contract, tortious interference with business relationships, tortious
interference with contracts, and disparagement of a perishable food product, and sought injunctive relief. A settlement was reached
in this matter and Agreed Final Judgment and Permanent Injunction was entered on April 8, 2020.
(m)
Cause No. DC-19-20587; Sharing Services Global Corporation f/k/a Sharing Services, Inc. v. Amber-Lynn Beers-Hutchinson,
n/k/a Amber-Lynn Cantrell, pending in the 192nd Judicial District of Dallas County, Texas. On December 30,
2019, the Company filed a lawsuit against a former contractor for breach of contract. The defendant in this matter filed a
counterclaim, asserting defamatory conduct engaged in by the Company. This matter remains pending.
(n)
On December 4, 2019, Entrepreneur Media, Inc. (“EMI”) filed a Notice of Opposition in response to the “Elepreneurs”
trademark application filed by SHRG IP Holdings, LLC, a wholly owned subsidiary of the Company. This opposition proceeding
is now before the Trademark Trial and Appeal Board of the United States Patent and Trademark Office (“TTAB”).
On April 13, 2020, SHRG IP Holdings, LLC filed an answer to the Notice of Opposition. Legal counsel for the parties held a mandatary
discovery conference on May 12, 2020. This matter remains pending.
(o)
On May 20, 2020, the Company (through its legal counsel, Jones, Davis & Jackson, PC) received a demand letter from
legal counsel representing a former employee of the Company. The Company has denied the claim of this at-will employee and this
matter remains pending.
(p)
Company subsidiaries Elevacity Holdings, LLC, Elevacity U.S., LLC, Elepreneurs Holdings, LLC and Elepreneurs U.S., LLC (collectively,
the “Subsidiaries”) received notice of a dispute with a former officer of such Subsidiaries regarding severance payments
allegedly due under an executive employment agreement. The Company and its Subsidiaries have disputed this matter, and the issues
between the parties remain outstanding.
(q)
In March 2019, the Company engaged in preliminary discussions with various independent contractor distributors of the Subsidiaries
regarding a previously reported dispute concerning the issuance of stock warrants based on the satisfaction of certain individual
sales production metrics. The Company previously recorded a liability of $0.1644 per share for the projected resolution of this
matter, which remains pending.
NOTE
18 - BUSINESS SEGMENT AND GEOGRAPHIC AREA INFORMATION
Business
Segments
The
Company, directly or through its subsidiaries, markets and sells its products and services directly to consumers, through its
independent sales force. In December 2017, the Company launched its health and wellness product line under the name Elevate. The
Company’s determination of its reportable segments is based on how its chief operating decision makers manage the business.
The
Company’s segment information is as follows:
|
|
Fiscal Year Ended April 30,
|
|
|
|
2020
|
|
|
2019
|
|
Net sales
|
|
|
|
|
|
|
|
|
Health and wellness products
|
|
$
|
129,024,888
|
|
|
$
|
83,483,841
|
|
Other
|
|
|
2,365,018
|
|
|
|
2,439,380
|
|
Total net sales
|
|
$
|
131,389,906
|
|
|
$
|
85,923,221
|
|
Operating earnings (loss):
|
|
|
|
|
|
|
|
|
Segment gross profit:
|
|
|
|
|
|
|
|
|
Health and wellness products
|
|
$
|
91,831,033
|
|
|
$
|
55,477,170
|
|
Other
|
|
|
1,683,257
|
|
|
|
1,649,115
|
|
Total segment gross profit
|
|
|
93,514,290
|
|
|
|
57,126,285
|
|
Selling and marketing expenses
|
|
|
60,814,242
|
|
|
|
43,956,495
|
|
General and administrative expenses
|
|
|
23,004,747
|
|
|
|
14,269,984
|
|
Consolidated operating earnings (loss)
|
|
$
|
9,695,301
|
|
|
$
|
(1,100,194
|
)
|
Total Assets:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
23,347,464
|
|
|
$
|
14,442,146
|
|
Corporate
|
|
|
1,229,894
|
|
|
|
1,561,877
|
|
Consolidated total assets
|
|
$
|
24,577,358
|
|
|
$
|
16,004,023
|
|
Payments for property and equipment:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
152,814
|
|
|
$
|
281,535
|
|
Corporate
|
|
|
8,043
|
|
|
|
14,818
|
|
Consolidated payments for property and equipment
|
|
$
|
160,857
|
|
|
$
|
296,353
|
|
Depreciation and amortization:
|
|
|
|
|
|
|
|
|
Health and wellness
|
|
$
|
122,417
|
|
|
$
|
74,732
|
|
Corporate
|
|
|
6,443
|
|
|
|
8,303
|
|
Consolidated depreciation and amortization
|
|
$
|
128,860
|
|
|
$
|
83,035
|
|
Geographic
Area Information
During
the fiscal year ended April 30, 2020 and 2019, approximately 95% and 96%, respectively, of our consolidated net sales are to customers
and/or independent distributors located in the U.S. (based on the customer’s shipping address). The Company expects its
sales to customers and/or independent distributors located outside the U.S. to increase in the future and plans to provide disclosure
about its sales by geographic area. All the Company assets are located in the U.S.
NOTE
19 - SUBSEQUENT EVENTS
On
May 13, 2020, a commercial bank granted to the Company a loan (the “Loan”) in the amount of $1,040,400, which is administered
under the authority and regulations of the U.S. Small Business Administration pursuant to the Paycheck Protection Program (the
“PPP”) of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES
Act”). The Loan, which is evidenced by a note dated May 13, 2020, bears interest
at an annual rate of 1.0% and matures on May 13, 2022. The Note may be prepaid without
penalty, at the option of the Company, at any time prior to maturity. Proceeds from loans granted under the CARES Act are intended
to be used for payroll, costs to continue employee group health care benefits, rent, utilities, and certain other qualified costs
(collectively, “qualifying expenses”). The Company intends to use the loan proceeds for qualifying expenses. The Company’s
borrowings under the Loan may be eligible for loan forgiveness if used for qualifying expenses incurred during the “covered
period,” as defined in the CARES Act, except that the amount of loan forgiveness is limited to the amount of qualifying
expenses incurred during the 8-week period commencing on the loan effective date. In addition, the amount of any loan forgiveness
may be reduced if there is a decrease in the average number of full-time equivalent employees of the Company during the covered
period, compared to the comparable period in the prior calendar year. The Company’s indebtedness, after any such loan forgiveness,
is payable in 18 equal monthly installments commencing on December 13, 2020, with all amounts due and payable by the maturity
date.
As
discussed in Note 15, under the terms of the Accommodation Agreement, the Company awarded to the debtor entity, a put option to
sell to the Company up to 5.0 million shares of the Company’s common stock at $0.10 per share, subject to certain conditions.
Under the terms of the Accommodation Agreement, as amended, during the period from July 1, 2020 to June 30, 2021, the debtor entity
has the option to sell to the Company no more than 1,000,000 shares in any 30-day period. Consistent with such terms, effective
July 1, 2020, the debtor entity exercised its put option whereas the Company is obligated to purchase 1,000,000 shares on the
first day of each month, commencing on July 1, 2020 and ending on November 1, 2020. The Company intends to pay for this share
repurchase with cash on hand and future cash flows from operating activities.
As
discussed in Note 17, In September 2019, the Company and 212 Technologies, LLC (“212 Technologies”) entered into a
Release and Settlement Agreement (the “Settlement Agreement”). Pursuant to the Settlement Agreement, the parties,
among other things rescinded a certain “Stakeholder & Investment Agreement” dated May 21, 2017 and 212 Technologies
returned 5,628,750 shares of the Company’s Series A Preferred Stock. On July 1, 2020, the Company retired these shares.